Global Vocal Biomarkers Market By Overview
Vocal Biomarkers Market size was valued at about USD 2.6 Billion in 2024 and expected to grow at CAGR of 15.10% to extend a value of USD 9.4 Billion by 2034.
Sound vibrations have been used as biomarkers in the diagnosis of various mental health disorders such as anxiety disorders, attention deficit and depression. Recent advancement in research on these aspects of sound of individual has led to emergence of the vocal biomarkers, which helps to detect, record and analyze the various types of disease based on sound characteristics. Advantage with vocal biomarkers is that it can be used to diagnose even patient who is remotely located. This makes it ideal diagnostic tool for telemedicine and related healthcare delivery. Moreover, vocal biomarker would be cost effective due to its noninvasive nature as against traditional biomarker, which are costly and causes significant healthcare burden for governments as well as insurance payer organization. In addition, these biomarkers would allow self-diagnosis as well as self-medication which would significantly increase the demand for vocal biomarkers in near future.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Vocal Biomarkers Market By Dynamics
Increasing incidence of the mental disorder
Important driver responsible for growth of vocal biomarkers market are increasing incidence of the mental disorder, neurological disorder and chronic disease such as cardiovascular disease. According to Parkinson’s Foundation data, close to one million people will be living with Parkinson\'s disease in the U.S. by 2020.Approximately 60,000 U.S. population are diagnosed with Parkinson\'s disease each year. Moreover chronic disease causes greatest number of deaths worldwide which would lead to increased focus on early diagnosis of these disease. In addition increased commercial activities and academic focus to develop vocal biomarker would help to early launch of vocal biomarker based products into the market. Early discovery of disease, especially in the event of serious illness, might be the difference between life and death for a person. Technology has aided in the development of various innovative technologies that assist doctors and patients in detecting diseases at an early stage, lowering mortality rates. The voice biomarker is one such advancement in medical science. A biomarker is a symptom or medical condition that affects the human body. It is the voice pattern in the case of vocal biomarkers. The market for vocal biomarkers has been steadily rising in recent years and is projected to continue to do so in the coming years.
Global Vocal Biomarkers Market By Segmentation
Vocal biomarkers market is segmented based application, end user and region.
On the basis of application, vocal biomarker market is segmented into (Psychiatric Disorders, Parkinson’s disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and others). On the basis of end user, vocal biomarkers market is segmented into Hospitals, Health Insurers, Academic Institutes, and Government Organizations.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Vocal Biomarkers Market accounted for US$ 1.65 billion in 2020 and is estimated to be US$ 6.18 billion by 2030 and is anticipated to register a CAGR of 14.1%. On region the Global Vocal Biomarker Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The major shareholder in the vocal biomarkers market is North America, which has the most technical and healthcare breakthroughs. Apart from health, the increased focus on national security and the desire to maintain the status of world superpower is driving demand for vocal biomarkers in the defence sector. Europe is also vital to the worldwide market for voice biomarkers. Existing players are attracted by the predicted increase in demand from Asia Pacific. The market for vocal biomarkers will rise as countries like India and China improve their defence and healthcare systems.
Report scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 2.6 Billion |
|
Projected Market Size 2034 |
US$ 9.4 Billion |
|
CAGR Growth Rate |
15.1% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Billion & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Therapeutic Applications: Psychiatric Disorders, Parkinson’s Disease, Cognitive Impairment, Brain Trauma Injury, Respiratory Disorders, Cardiovascular Disorders and Others By End User: Hospitals, Health Insurers, Academic Institutes, and Government Organizations |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Vocal Biomarkers Market report based on Therapeutic Application, End-User and Region.
Vocal Biomarkers Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Germany
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- U.S.
Global Vocal Biomarkers Market By Key Players
Key players operating in the vocal biomarkers market include Beyond Verbal, Inc., Sonde Health, IBM, Cogito Corporation and Sharecare, Inc.
Global Vocal Biomarkers Market By Company Profile
- Beyond Verbal Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sonde Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- IBM
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cogito Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sharecare, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Vocal Biomarkers Market By Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Vocal Biomarkers Strategies
- Key Questions this Study will Answer
- Market Snippet, By Therapeutics Application
- Market Snippet, By End-User
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation , By Therapeutics application, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Psychiatric Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Parkinson’s Disease
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cognitive Impairment
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Brain Trauma Injury
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Respiratory Disordrs
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Cardiovascular Disorders
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Market Segmentation , By End-User, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Health Insurers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Academic Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Government Organizations
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Market , By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Therapeutics Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Therapeutics Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Therapeutics Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Therapeutics Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Therapeutics Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- Beyond Verbal Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sonde Health
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- IBM
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Cogito Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Sharecare, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
Vocal biomarkers market is segmented based application, end user and region.
Important driver responsible for growth of vocal biomarkers market are increasing incidence of the mental disorder, neurological disorder and chronic disease such as cardiovascular disease
Key players operating in the global vocal biomarkers market include Beyond Verbal, Inc., Sonde Health, IBM, Cogito Corporation and Sharecare, Inc.
North America is expected to account major market share as compared to that of other regions.
Lack of awareness and availability of product are major restrains for this market